NVAX
Novavax Inc
10.60$
+0.5%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Cash Flow
Novavax Inc (NVAX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at -75 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -40 | -177 | -84 | 314 | -145 | -173 | -186 | -127 | 108 | -39 | -32 | -75 | -39 | |
| 11 | 11 | 12 | 11 | 13 | 13 | 8.3 | 7.6 | 6.6 | 5.1 | 3.1 | 3.1 | 18 | |
| 21 | 16 | 12 | 14 | 12 | 10 | 10 | 9.2 | 8.5 | 8.0 | 7.7 | 8.1 | 32 | |
| 36 | – | – | – | – | – | – | – | – | – | – | – | – | |
| 44 | -50 | 34 | 115 | -52 | -49 | -740 | -240 | 166 | -74 | -25 | 22 | 90 | |
| 18 | 9.1 | 7.3 | 3.1 | 2.0 | 2.3 | 1.6 | 0.2 | 2.0 | 2.1 | 1.3 | 1.3 | 6.6 | |
| -18 | -9.1 | -7.3 | -373 | 32 | 144 | -73 | 111 | -137 | 20 | -28 | 35 | -110 | |
| – | – | – | – | – | – | – | -5.3 | 0.8 | -0.3 | -8.2 | 8.2 | 0.5 | |
| 1.8 | – | – | – | -0.5 | -2.8 | -2.2 | -0.6 | 42 | -6.3 | 46 | -47 | 34 | |
| 197 | 100 | 5.9 | 258 | -0.1 | -3.4 | -7.1 | -1.0 | 42 | -6.6 | 38 | 9.4 | 83 | |
| 148 | -83 | -88 | 200 | -107 | -43 | -267 | -9.5 | 14 | -27 | -23 | -31 | -67 | |
| -58 | -186 | -91 | 311 | -147 | -175 | -187 | -128 | 106 | -42 | -34 | -74 | -44 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.